Literature DB >> 3829496

Lewis lung carcinoma (3LL) cells treated in vitro with ultraviolet radiation show reduced metastatic ability due to an augmented immunogenicity.

S Peppoloni, R B Herberman, E Gorelik.   

Abstract

The metastatic ability of 3LL tumor following in vitro irradiation with ultraviolet (u.v.) light was studied. Tumor cells were exposed to two courses of u.v.-irradiation (3LL X 2u.v. cells) and after two weeks of culture they were inoculated intravenously (i.v.) into syngeneic mice. These cells produced significantly fewer pulmonary metastases than the untreated population. In addition, intrafootpad (i.f.p.) injections of 3LL X 2u.v. cells into immunocompetent animals induced tumors only in 40 per cent of recipients. Interestingly, in normal mice with progressively growing 3LL X 2u.v. tumors, the formation of spontaneous pulmonary metastases was prevented, whereas metastatic foci were observed in 70 per cent of the nude recipients. The metastatic properties of u.v.-treated tumor cells were further analysed by using individual clones with varying immunogenicity. We found that variants with augmented immunogenicity also showed a parallel decrease in metastatic potential. Studies on H-2 antigen expression in different clones revealed that immunogenic and low metastatic variants expressed levels of H-2 antigens higher than the tumorigenic and metastatic clones. Finally, by using cyclophosphamide (Cy) treatment and adoptive transfer of immune spleen cells were able to eradicate macroscopic 3LL pulmonary metastasis. These results demonstrate that the decrease of metastatic ability in u.v.-treated cells was mainly due to an increase in their immunogenicity and H-2 antigen expression.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3829496     DOI: 10.1007/bf00116625

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  30 in total

1.  Non-metastasising variants selected from metastasising melanoma cells.

Authors:  T W Tao; M M Burger
Journal:  Nature       Date:  1977-12-01       Impact factor: 49.962

2.  Distribution of human Class I (HLA-A,B,C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin.

Authors:  P G Natali; A Bigotti; M R Nicotra; M Viora; D Manfredi; S Ferrone
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

3.  Induction of highly immunogenic variants of Lewis lung carcinoma tumor by ultraviolet irradiation.

Authors:  S Peppoloni; R B Herberman; E Gorelik
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

4.  Role of NK cells in the control of metastatic spread and growth of tumor cells in mice.

Authors:  E Gorelik; R H Wiltrout; K Okumura; S Habu; R B Herberman
Journal:  Int J Cancer       Date:  1982-07-15       Impact factor: 7.396

5.  An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts.

Authors:  N Isakov; M Feldman; S Segal
Journal:  Invasion Metastasis       Date:  1982

6.  Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection.

Authors:  R Wallich; N Bulbuc; G J Hämmerling; S Katzav; S Segal; M Feldman
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

7.  Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.

Authors:  E Gorelik; S Segal; M Feldman
Journal:  J Natl Cancer Inst       Date:  1980-12       Impact factor: 13.506

8.  Role of natural killer cells in the destruction of circulating tumor emboli.

Authors:  N Hanna; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1980-10       Impact factor: 13.506

9.  Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.

Authors:  N Isakov; M Feldman; S Segal
Journal:  J Natl Cancer Inst       Date:  1981-05       Impact factor: 13.506

10.  Immunity as the predominant factor determining metastasis by murine lymphomas.

Authors:  G C Davey; G A Currie; P Alexander
Journal:  Br J Cancer       Date:  1979-10       Impact factor: 7.640

View more
  1 in total

1.  IFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread.

Authors:  M Zöller
Journal:  Clin Exp Metastasis       Date:  1988 Sep-Oct       Impact factor: 5.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.